These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740 [TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor. Ozaki Y; Satoh K; Yatomi Y; Miura S; Fujimura Y; Kume S Biochim Biophys Acta; 1995 Apr; 1243(3):482-8. PubMed ID: 7537105 [TBL] [Abstract][Full Text] [Related]
6. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958 [TBL] [Abstract][Full Text] [Related]
7. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906 [TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224 [TBL] [Abstract][Full Text] [Related]
9. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. Grainick HR; Williams SB; Coller BS J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249 [TBL] [Abstract][Full Text] [Related]
10. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830 [TBL] [Abstract][Full Text] [Related]
11. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469 [TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin. Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727 [TBL] [Abstract][Full Text] [Related]
13. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346 [TBL] [Abstract][Full Text] [Related]
14. Ristocetin-mediated interaction of human von Willebrand factor with platelet glycoprotein lb evokes a transient calcium signal: observations with Fura-PE3. Milner EP; Zheng Q; Kermode JC J Lab Clin Med; 1998 Jan; 131(1):49-62. PubMed ID: 9452127 [TBL] [Abstract][Full Text] [Related]
15. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201 [TBL] [Abstract][Full Text] [Related]
16. Type IIB von Willebrand factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets. Francesconi M; Casonato A; Pontara E; Dalla Via L; Girolami A; Deana R Biochem Biophys Res Commun; 1995 Sep; 214(1):102-9. PubMed ID: 7669029 [TBL] [Abstract][Full Text] [Related]
17. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations. de Romeuf C; Hilbert L; Mazurier C Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC; Zaleski A; Nichols WL; Olson JD J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492 [TBL] [Abstract][Full Text] [Related]
19. Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets. Jackson SP; Schoenwaelder SM; Yuan Y; Rabinowitz I; Salem HH; Mitchell CA J Biol Chem; 1994 Oct; 269(43):27093-9. PubMed ID: 7523416 [TBL] [Abstract][Full Text] [Related]
20. The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets. Liu J; Pestina TI; Berndt MC; Steward SA; Jackson CW; Gartner TK J Thromb Haemost; 2004 Dec; 2(12):2213-22. PubMed ID: 15613029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]